(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of 30.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.4%.
Ceribell's revenue in 2026 is $89,063,000.On average, 10 Wall Street analysts forecast CBLL's revenue for 2026 to be $4,343,797,827, with the lowest CBLL revenue forecast at $4,094,612,891, and the highest CBLL revenue forecast at $4,527,110,612. On average, 10 Wall Street analysts forecast CBLL's revenue for 2027 to be $5,579,182,962, with the lowest CBLL revenue forecast at $5,219,709,225, and the highest CBLL revenue forecast at $5,874,290,198.
In 2028, CBLL is forecast to generate $7,136,777,018 in revenue, with the lowest revenue forecast at $6,713,689,604 and the highest revenue forecast at $7,563,252,143.